PG
RMD icon

PEAK6 Group’s ResMed RMD Stock Holding History

PEAK6 Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$498K Buy
4,807
+762
+19% +$77.1K ﹤0.01% 2598
2018
Q1 		$398K Buy
+4,045
New +$382K ﹤0.01% 2769
2017
Q1 		– Sell
-15,810
Closed -$981K – 4873
2016
Q4 		$981K Buy
+15,810
New +$968K 0.01% 1883
2014
Q4 		– Sell
-759
Closed -$39.6K – 5070
2014
Q3 		$37K Buy
+759
New +$38.7K ﹤0.01% 4240
2013
Q4 		– Sell
-6,538
Closed -$331K – 5362
2013
Q3 		$173K Buy
+6,538
New +$317K ﹤0.01% 3786

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Group's RMD Position: Q2 2018 in Review

PEAK6 Group increased its ResMed (RMD) stake by 19% in Q2 2018, buying an estimated $77.1K and bringing the position to 4,807 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #2598.

PEAK6 Group first reported a position in RMD in Q3 2013 and has held it in 5 quarters since. The position peaked at $981K in Q4 2016. 465 funds tracked by Wall St. Rank hold RMD as of Q2 2018.

  • PEAK6 Group held 4,807 shares of ResMed worth $498K as of Q2 2018.
  • PEAK6 Group bought 762 ResMed shares in Q2 2018, an estimated $77.1K.
  • ResMed made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2598 holding.
  • PEAK6 Group first reported a position in ResMed in Q3 2013 and has held it in 5 quarters since.
  • PEAK6 Group's ResMed position peaked at $981K in Q4 2016.
  • 465 funds tracked by Wall St. Rank held ResMed as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.